Global Worker Confidence Plunges to Record Low Amid AI Job Displacement Fears AI Agents for Email Sorting How Businesses Could Boost Productivity and Cut Costs USChina Summit Yields Soybean and Rare Earth Deals Tariff Cut Discussions Continue Vestas Wind Systems Stock Declines After Company Warns Margins Near Guidance Floor US Benchmark Indices Hold Firm With Market Sentiment Remaining Upbeat QLine Biotech IPO Allotment Expected Today Grey Market Premium at 115 PAGS Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Mixed Market Reaction Weibo WB Q3 2025 Earnings EPS of 042 as Stock Edges Higher Amid Unclear Revenue Picture RideNow Group Inc RDNW Q1 2026 Earnings SmallerThanExpected Loss Provides Modest Relief FSS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction MGRX Q3 2025 Earnings Narrowing Losses as Strategic Pivot Gains Momentum Ethos Technologies LIFE Q1 2026 Earnings Stellar EPS Surprise Fails to Lift Stock as Revenue Details Remain Elusive Abeona Therapeutics ABEO Slips 145 as Stock Tests Key Support at 517 FG Merger II Corp FGMC Holds Near 1033 as SPAC Awaits Merger Catalyst BJs Wholesale Club BJ Gains 26 as Retail Sector Finds Footing Prairie Operating Co PROP Surges Over 9 as It Nears Key Resistance Level Acco Brands ACCO Gains 25 as Stock Holds Above Key Support European Reindustrialisation Faces Funding Challenge Amid AI Investment Surge Cable One CABO Q1 2026 Earnings Earnings Beat Estimates Stock Surges 965 21Shares Dogecoin ETF TDOG Shows Cautious Pullback Amidst Crypto ETF Volatility Amplitech Group Rights AMPGR Decline 781 as Stock Tests Key Support Levels Rising Dragon Acquisition Corp RDAC Surges Nearly 10 as SPAC Shares Break Higher Intellia Therapeutics NTLA Nears Key Support Amid Continued Downtrend Trailblazer Acquisition Corp Unit BLZRU Holds Steady Near 1021 as Trading Activity Remains Subdued Chegg Inc CHGG Surges 84 as Stock Bounces From Key Support Zone Rani Therapeutics RANI Tests Key Resistance at 100 After Marginal Gain Crinetics Pharmaceuticals CRNX Slips 152 as Biotech Sentiment Remains Cautious